Explore Pharmacogenetic Diversity with PharmFreq....

Explore Pharmacogenetic Diversity with PharmFreq....

IKP | November 2024
www.pharmfreq.com

Polymorphisms in drug-metabolizing enzymes, drug transporters, and major histocompatibility complex genes lead to significant inter-individual differences in drug efficacy and safety. The patterns and complexities of these variations vary across populations. In close collaboration, experts from IKP and Karolinska have collected and reviewed an extensive data set to create an easily accessible, interactive website. The site PharmFreq serves as a global repository of pharmacogenetic frequency data from over 10 million individuals across worldwide more than half of the countries, aggregating information on pharmacogenomic alleles from more than 1,200 studies. This platform enables users to easily explore pharmacogenetic diversity and supports research in underrepresented populations.

Visit the website at pharmfreq.com

Key Findings

The accompanying manuscript (available as a PDF or via DOI) reveals that the majority of studies focus primarily on East Asian and European populations. The number of studies conducted in each country correlates with population size and GDP, highlighting significant coverage disparities. Additionally, the paper outlines various use cases demonstrating the resource's utility for the clinical implementation of pharmacogenomics and research initiatives.

PharmFreq_horizontel

Join us in advancing the understanding of pharmacogenetic diversity and improving drug therapy across various populations by sharing your pharmacogenomic allele data with us.

Dr. Roman Tremmel
Research Group Leader Pharmacogenomics and Digital Health
Tel+49-711-8101 2061
roman.tremmel@ikp-stuttgart.de
Go to profile
Prof. Dr. Volker Lauschke
Deputy Head at IKP
Research Group Leader Microphysiological Tissue Models
Go to profile